R&D
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 1–12 of 23 articles
Quick answer
NovaPharmaNews R&D hub for NMPA covers 23 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Piyush Goyal Invites Global Pharma Firms to Partner With India
Blood pressure and ischemic stroke risk in dementia: nationwide cohort findings
Nektar Therapeutics pipeline update: REZPEG clinical programs and regulatory context
Areas with Risk of Dengue: CDC map, criteria, and global reach
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Data at ADA 2026
Poly Medicure appoints Indranil Mukherjee as CEO, APAC & India: Strategic implications for pharma BD teams
Cell Therapy Packaging Market Size & Share Report, 2033: Key Trends and Forecasts
Orion Pharma's ODM-212 Shows Favorable Safety in Phase 1/2 TEADES Trial for Advanced Solid Tumours
The Pharma Choke Point: A Strategic Risk for U.S. Pharmaceutical Supply Chains
Ecosystem Over Geography: Life Sciences Location Strategy in APAC
Helus Pharma to Participate in the Jefferies Global Healthcare Conference: Strategic Implications for Analysts and BD Teams
Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.